* Orthofix Medical Inc OFIX.OQ reported quarterly adjusted
earnings of 2 cents per share for the quarter ended in June.
The mean expectation of four analysts for the quarter was for a
loss of 47 cents per share.
* Revenue rose 58.4% to $187.02 million from a year ago;
analysts
expected $185.63 million.
* Orthofix Medical Inc's reported EPS for the quarter was a
loss
of $1.07.
* The mean earnings estimate of analysts had risen by
about 20% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Orthofix Medical Inc shares had fallen by 0.6% this
quarter and
lost 12.5% so far this year.
* The company reported a quarterly loss of $39.43 million.
* Wall Street's median 12-month price target for Orthofix
Medical
Inc is $30.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 9 at 05:34 a.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.47 0.02 Beat
Mar. 31 2023 -0.51 -0.10 Beat
Dec. 31 2022 0.10 0.19 Beat
Sep. 30 2022 0.12 0.13 Beat